Reconvalescent blood products, Passive vaccine

Aus coViki
Wechseln zu: Navigation, Suche
GET 2020. Current studies of convalescent plasma therapy for COVID-19 may underestimate risk of antibody-dependent enhancement. Extract
  • GET ä. Treatment With Convalescent Plasma for Critically Ill Patients With SARS-CoV-2 Infection Extract
  • anti covid mab
  • acmab 47d11
  • GET ä. Structural Basis for Potent Neutralization of Betacoronaviruses by Single-Domain Camelid Antibodies Extract
  • GET 2020. Impact of immune enhancement on Covid-19 polyclonal hyperimmune globulin therapy and vaccine development Extract
  • GET ä. Successful treatment of plasma exchange followed by intravenous immunogloblin in a critically ill patient with 2019 novel coronavirus infection Extract
  • GET 2020. Perspectives on therapeutic neutralizing antibodies against the Novel Coronavirus SARS-CoV-2 Extract
  • GET 2020. Could Intravenous Immunoglobulin Collected from Recovered Coronavirus Patients Protect against COVID-19 and Strengthen the Immune System of New Patients? Extract
  • GET 2020. Deployment of convalescent plasma for the prevention and treatment of COVID-19 Extract
  • GET ä. Challenges of Convalescent Plasma Therapy on COVID-19 Extract
  • GET ä. The convalescent sera option for containing COVID-19 Extract
  • GET ä. Effect of Convalescent Plasma Therapy on Viral Shedding and Survival in COVID-19 Patients Extract
GET ä. Duration of serum neutralizing antibodies for SARS-CoV-2: Lessons from SARS-CoV infection Extract
  • GET 2020. Use of Convalescent Plasma Therapy in Two COVID-19 Patients with Acute Respiratory Distress Syndrome in Korea Extract
  • GET 2020. Treatment of 5 Critically Ill Patients With COVID-19 With Convalescent Plasma Extract
  • GET ä. COVID-19 convalescent plasma transfusion Extract
  • GET 2020. Convalescent plasma as a potential therapy for COVID-19 Extract
  • GET ä. Convalescent plasma: A possible treatment of COVID-19 in India Extract
  • GET 2020. Immunoglobulins or convalescent plasma to tackle COVID-19: buying time to save lives - current situation and perspectives Extract
  • GET 2020. Effectiveness of convalescent plasma therapy in severe COVID-19 patients Extract
  • GET ä. Treatment for emerging viruses: Convalescent plasma and COVID-19 Extract
  • GET ä. Convalescent plasma in Covid-19: Possible mechanisms of action Extract
  • GET ä. COVID-19 Convalescent Plasma: Now Is the Time for Better Science Extract
  • GET ä. Convalescent Plasma: Therapeutic Hope or Hopeless Strategy in the SARS-CoV-2 Pandemic Extract
  • GET 2020. Covid-19: FDA approves use of convalescent plasma to treat critically ill patients Extract
GET 2020. Convalescent donor SARS-COV-2-specific cytotoxic T lymphocyte infusion as a possible treatment option for COVID-19 patients with severe disease has not received enough attention till date Extract
  • GET 2020. Coronavirus drugs: Using plasma from recovered patients as a treatment for COVID-19 Extract
  • GET 2020. Convalescent plasma transfusion for the treatment of COVID-19: Systematic review Extract
  • GET 2020. Treatment with convalescent plasma for COVID-19 patients in Wuhan, China Extract
  • GET 2020. COVID-19: Herd Immunity and Convalescent Plasma Transfer Therapy Extract
  • GET 2020. Convalescent plasma in Covid-19: Possible mechanisms of action Extract
  • GET 2020. Operational protocol for donation of anti-COVID-19 convalescent plasma in Italy Extract
  • GET 2020. Points to consider in the preparation and transfusion of COVID-19 convalescent plasma Extract
  • GET 2020. Collecting and evaluating convalescent plasma for COVID-19 treatment: why and how? Extract
  • GET 2020. Convalescent plasma to treat coronavirus disease 2019 (COVID-19): considerations for clinical trial design Extract
  • GET 2020. COVID-19 convalescent plasma: phase 2 Extract
  • GET 2020. Convalescent Plasma to Treat COVID-19: Possibilities and Challenges Extract
  • GET 2020. Testing an Old Therapy Against a New Disease: Convalescent Plasma for COVID-19 Extract
GET 2020. Impact of immune enhancement on Covid-19 polyclonal hyperimmune globulin therapy and vaccine development Extract
  • GET 2020. Convalescent Plasma Therapy for Corona Virus Disease 2019: a Long Way to Go but Worth Trying Extract
  • GET 2020. The resurgence of convalescent plasma therapy Extract
GET 2020. A Review on Applications of Computational Methods in Drug Screening and Design Extract
  • GET 2020. Hyper-immune/convalescent plasma: an old option and a valid strategy for treatment of COVID-19? Extract
  • GET 2020. Challenges in the Production of Convalescent Hyperimmune Plasma in the Age of COVID-19. Extract
  • GET 2020. Convalescent plasma for patients with COVID-19. Extract
  • GET 2020. Get rid of the bad first: Therapeutic plasma exchange with convalescent plasma for severe COVID-19. Extract
  • GET 2020. [Application of convalescent plasma therapy on novel coronavirus infection]. Extract
  • GET 2020. Convalescent plasma therapy: A passive therapy for an aggressive COVID-19. Extract
  • GET 2020. Efficacy and safety of convalescent plasma for severe COVID-19 based on evidence in other severe respiratory viral infections: a systematic review and meta-analysis. Extract
  • GET 2020. A Randomized Trial of Convalescent Plasma for COVID-19-Potentially Hopeful Signals. Extract
  • GET 2020. Convalescent plasma or hyperimmune immunoglobulin for people with COVID-19: a rapid review. Extract
  • GET 2020. Development of passive immunity against SARS-CoV-2 for management of immunodeficient patients-a perspective. Extract
  • GET 2020. Battle against COVID-19: Efficacy of Convalescent Plasma as an emergency therapy. Extract
GET 2020. Harnessing HLA-E-restricted CD8 T lymphocytes for adoptive cell therapy of severe COVID-19 patients. Extract


  • GET 2020. Active Therapy with Passive Immunotherapy May Be Effective in the Fight against Covid-19. Extract
  • GET 2020. Efficacy of therapeutic plasma exchange in severe COVID-19 patients. Extract
  • GET 2020. Position paper on the preparation of immune plasma to be used in the treatment of patients with COVID-19. Extract
  • GET 2020. Convalescent plasma therapy in the treatment of COVID-19: Practical considerations: Correspondence. Extract
  • GET 2020. Plasma from donors recovered from the new Coronavirus 2019 as therapy for critical patients with COVID-19 (COVID-19 plasma study): a multicentre study protocol. Extract
  • GET 2020. Effect of Convalescent Plasma Therapy on Time to Clinical Improvement in Patients With Severe and Life-threatening COVID-19: A Randomized Clinical Trial. Extract
  • GET 2020. Treatment of Coronavirus Disease 2019 (COVID-19) Patients with Convalescent Plasma. Extract
  • GET 2020. Early safety indicators of COVID-19 convalescent plasma in 5,000 patients. Extract
  • GET 2020. Potent neutralizing antibodies against SARS-CoV-2 identified by high-throughput single-cell sequencing of convalescent patients' B cells. Extract
  • GET 2020. Identification of SARS-CoV RBD-targeting monoclonal antibodies with cross-reactive or neutralizing activity against SARS-CoV-2. Extract
  • GET 2020. Feasibility of a Pilot Program for COVID-19 Convalescent Plasma Collection in Wuhan, China. Extract
  • GET 2020. Use of COVID-19 convalescent plasma in low- and middle-income countries: a call for ethical principles and the assurance of quality and safety. Extract
  • GET 2020. Convalescent plasma for COVID-19: Back to the future. Extract
  • GET 2020. How did we rapidly implement a convalescent plasma program? Extract
  • GET 2020. COVID-19: are neutralizing antibodies neutralizing enough? Extract
  • GET 2020. COVID-19 convalescent plasma donor recruitment: beware the Faustian bargains. Extract
  • GET 2020. Convalescent plasma, an apheresis research project targeting and motivating the fully recovered COVID 19 patients: A rousing message of clinical benefit to both donors and recipients alike Extract
  • GET ä. Convalescent plasma, an apheresis research project targeting and motivating the fully recovered COVID 19 patients: A rousing message of clinical benefit to both donors and recipients alike Extract
GET 2020. Anti-A Isohemagglutinin titers and SARS-CoV2 neutralization: implications for children and convalescent plasma selection. Extract
  • GET 2020. Convalescent plasma: A possible treatment protocol for COVID- 19 patients suffering from diabetes or underlying liver diseases. Extract
  • GET 2020. Why should we use convalescent plasma for COVID-19? Extract
  • GET 2020. Convalescent Plasma and COVID-19. Extract
  • GET 2020. Early experience with convalescent plasma as immunotherapy for COVID-19 in China: Knowns and unknowns. Extract
  • GET 2020. The role of passive immunization in the age of SARS-CoV-2: an update. Extract
  • GET 2020. Passive Immunity for Coronavirus Disease 2019: A Commentary on Therapeutic Aspects Including Convalescent Plasma. Extract
  • GET 2020. Guidance for the Procurement of COVID-19 Convalescent Plasma: Differences between High and Low-Middle Income Countries. Extract
GET 2020. Persistent viral RNA shedding after COVID-19 symptom resolution in older convalescent plasma donors. Extract
  • GET 2020. Corrected idiotic title: Therapeutic Plasma Exchange–Neutralizing Antibody Combination Therapy for Severe Coronavirus Disease 2019 (TPE-nAbs)for severe COVID-19. Extract
  • GET 2020. [Effect of convalescent plasma and immunoglobulin on patients with severe acute respiratory syndrome: a systematic review]. Extract
  • GET 2020. Coronaviruses pandemics: Can neutralizing antibodies help? Extract
  • GET 2020. Passive antibody therapy in COVID-19. Extract
  • GET 2020. A noncompeting pair of human neutralizing antibodies block COVID-19 virus binding to its receptor ACE2. Extract
  • GET 2020. Use of convalescent plasma in COVID-19 patients in China. Extract
  • GET 2020. Convalescent (immune) plasma treatment in a myelodysplastic COVID-19 patient with disseminated tuberculosis. Extract
  • GET 2020. Position paper on the preparation of immune plasma to be used in the treatment of patients with COVID-19. Extract
  • GET 2020. Successful treatment of a centenarian with coronavirus disease 2019 (COVID-19) using convalescent plasma. Extract
  • GET 2020. Recovery of severely ill COVID-19 patients by intravenous immunoglobulin (IVIG) treatment: A case series. Extract
  • GET 2020. ...rescue framework for the transfusion of best convalescent plasma to the most critical patients based on biological requirements via ml and novel MCDM methods. Extract
  • GET 2020. Inefficiency of Sera from Mice Treated with Pseudotyped SARS-CoV to Neutralize 2019-nCoV Infection. Extract
  • GET 2020. Antibodies to SARS-CoV-2 and their potential for therapeutic passive immunization. Extract
GET 2020. In Vivo Expressed Biologics for Infectious Disease Prophylaxis: Rapid Delivery of DNA-Based Antiviral Antibodies. Extract
  • GET 2020. Convalescent plasma therapy in the treatment of COVID-19: Some considerations: Correspondence. Extract
  • GET 2020. Appropriate selection of convalescent plasma donors for COVID-19. Extract
  • GET 2020. Improved Clinical Symptoms and Mortality on Severe/Critical COVID-19 Patients Utilizing Convalescent Plasma Transfusion. Extract
  • GET 2020. Use of Convalescent Plasma in Hospitalized Patients with Covid-19 - Case Series. Extract
  • GET 2020. A Potently Neutralizing Antibody Protects Mice against SARS-CoV-2 Infection. Extract
  • GET 2020. Effectiveness of intravenous immunoglobulin for children with severe COVID-19: a rapid review. Extract
  • GET 2020. Clinical use of Convalescent Plasma in the COVID-19 pandemic; a transfusion-focussed gap analysis with recommendations for future research priorities. Extract
  • GET 2020. Reflection on passive immunotherapy in those who need most: some novel strategic arguments for obtaining safer therapeutic plasma or autologous antibodies from recovered COVID-19 infected patients. Extract
  • GET 2020. Perspectives on the development of neutralizing antibodies against SARS-CoV-2. Extract
  • GET 2020. Identification of Human Single-Domain Antibodies against SARS-CoV-2. Extract
  • GET 2020. The use of convalescent plasma therapy and remdesivir in the successful management of a critically ill obstetric patient with novel coronavirus 2019 infection: A case report. Extract
  • GET 2020. Structural Basis for Potent Neutralization of Betacoronaviruses by Single-Domain Camelid Antibodies. Extract
  • GET 2020. Convalescent Plasma Therapy: Helpful Treatment of COVID-19 in a Kidney Transplant Recipient presenting with serve clinical manifestation and complex complications. Extract
  • GET 2020. Immunoglobulins in the treatment of COVID-19 infection: Proceed with caution! Extract
  • GET 2020. Convalescent plasma for persisting Covid-19 following therapeutic lymphocyte depletion: a report of rapid recovery. Extract
GET 2020. IgY - turning the page toward passive immunization in COVID-19 infection (Review). Extract
  • GET 2020. Monoclonal Antibodies for Prevention and Treatment of COVID-19. Extract
  • GET 2020. Potent neutralization of SARS-CoV-2 by human antibody heavy-chain variable domains isolated from a large library with a new stable scaffold. Extract
  • GET 2020. COVID-19 and SARS Coronavirus 2: Antibodies for the Immediate Rescue and Recovery Phase. Extract
  • GET 2020. Regulatory consideration on preparation and clinical use of COVID-19 convalescent plasma. Extract
  • GET 2020. Management of COVID-19 Virus Infection by Convalescent Plasma. Extract
  • GET 2020. Az elso ket sikeres, convalescens friss fagyasztott plazmaval torteno terapia hazai alkalmazasa intenziv osztalyon kezelt, kritikus allapotu, COVID-19-fertozesben szenvedo betegekben: (A COVID-19-pandemia orvosszakmai kerdesei) Extract
  • GET 2020. How blood from coronavirus survivors might save lives. Extract
  • GET 2020. INFUSION OF CONVALESCENT PLASMA IS ASSOCIATED WITH CLINICAL IMPROVEMENT IN CRITICALLY ILL PATIENTS WITH COVID-19: A PILOT STUDY. Extract
  • GET 2020. Can hyperimmune anti-CMV globulin substitute for convalescent plasma for treatment of COVID-19? Extract
  • GET 2020. Inmunoglobulinas por via intravenosa: una alternativa terapeutica a tener en cuenta en el paciente trasplantado renal con COVID-19. Extract
  • GET 2020. Convalescent plasma and covid-19 treatment. Extract
  • GET 2020. SARS-CoV-2 neutralizing antibody development strategies. Extract
  • GET 2020. A neutralizing human antibody binds to the N-terminal domain of the Spike protein of SARS-CoV-2. Extract
  • GET 2020. Antibody cocktail to SARS-CoV-2 spike protein prevents rapid mutational escape seen with individual antibodies. Extract
  • GET 2020. Isolation of potent SARS-CoV-2 neutralizing antibodies and protection from disease in a small animal model. Extract
  • GET 2020. Potent neutralizing antibodies from COVID-19 patients define multiple targets of vulnerability. Extract
  • GET 2020. Studies in humanized mice and convalescent humans yield a SARS-CoV-2 antibody cocktail. Extract
  • GET 2020. Broad neutralization of SARS-related viruses by human monoclonal antibodies. Extract
  • GET 2020. Non-optimal effectiveness of convalescent plasma transfusion and hydroxychloroquine in treating COVID-19: a case report. Extract
Meine Werkzeuge
Namensräume
Varianten
Aktionen
Navigation
Werkzeuge